NCT00083395 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Basso C, Thiene G, Nava A, Dalla Volta S
Arrhythmogenic right ventricular cardiomyopathy: a survey of the investigations at the University of Padua. Clin Cardiol. 1997 Apr;20(4):333-6.
DALLA VOLTA S, BATTAGLIA G, ZERBINI E
"Auricularization' of right ventricular pressure curve. Am Heart J. 1961 Jan;61:25-33.
Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y
Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982 Feb;65(2):384-98.

Utility of Isoproterenol Challenge Test to Detect Disease in Patients With Incomplete Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy

Details for clinical trial NCT00083395

Clinical trial NCT00083395 - References